35
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Clinical and Laboratory Findings in Immunocompetent Patients with Persistent Parvovirus B19 DNA in Bone Marrow

Pages 11-16 | Published online: 08 Jul 2009

  • Anderson LJ. Human Parvoviruses. J Infect Dis 1990; 161: 603–8.
  • Kurtzman GJ, Ozawa K, Cohen B, Hanson G, Oseas R, Young NS. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 1987; 317: 287–94.
  • Kurtzman GJ, Cohen B, Meyers P, Amunullah A, Young NS. Persistent B19 parvovirus infection as a cause of severe chronic anemia in children with acute lymphocytic leukemia. Lancet 1988; 2: 1159–62.
  • Graeve JLA, de Alarcon PA, Naides SJ. Parvovirus B19 infection in patients receiving cancer chemotherapy: the expanding spectrum of disease. Am J Pediatr Hematol Oncol 1989; 11: 441–4.
  • Weiland HT, Salimans MM, Fibbe WE, Kluin PM, Cohen BJ. Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant patient. Br J Haematol 1989; 71: 300.
  • Frickhofen N, Abkowitz JL, Safford M, Berry JM, AntunezdeMayolo J, Astrow A, et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 1990; 113: 926–33.
  • Pont J, Puchhammer-Stöckl E, Chott A, Popow-Kraupp T, Kienzer H, Postner G, et al. Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection. Br J Hematol 1992; 80: 160–5.
  • Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red-cell aplasia of 10 years’ duration due to persistent parvovirus B19 infection and its cure with immunoglobulin. N Engl J Med 1989; 321: 519–23.
  • Baurmann H, Schwarz TF, Oertel J, Serke S, Roggendorf M, Huhn D. Acute parvovirus B19 infection mimicking myelodysplastic syndrome of the bone marrow. Ann Hematol 1992; 64: 43.
  • Faden H, Gary GW, Anderson LJ. Chronic parvovirus infection in a presumably immunologically healthy woman. Clin Inf Dis 1992; 15: 595–7.
  • Hammarström L, Samuelsson J, Grimfors G. Subcutaneous gammaglobulin for patients with secondary hypogammaglobulinemia. Lancet 1995; 345: 382–3.
  • Broliden K, Tolfvenstam T, Ohlsson S, Henter. JI. Persistent B19 Parvovirus infection in pediatric malignancies. Med Ped Oncol 1998; 31: 66–72.
  • Wang FZ, Dahl H, Linde A, Brytting M, Ehrnst A, Ljungman P. Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 1996; 88: 3615–20.
  • Soderlund M, Brown CS, Spaan WJM, Hedman L, Hedman K. Epitope-type specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis 1995; 172: 1431–6.
  • Soderlund M, Brown CS, Cohen BJ, Hedman K. Accurate serodiagnosis of B19 parvovirus infections by measurements of IgG avidity. J Infect Dis 1995; 171: 710–3.
  • Bostic J, Koenig S. Quantitative analysis of parvovirus B19 neutralizing responses in immune sera by an RT-PCR based assay. J Infect Dis 1999, In press.
  • Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM, et al. Experimental parvoviral infection in humans. J Infect Dis 1985; 152: 257–65.
  • Liu W, Ittmann M, Liu J, et al. Human parvovirus B19 in bone marrows from adults with aquired immunodeficiency syndrome: a comparative study using in situ hybridization and immunohistochemistry. Hum Pathol. 1997; 28: 760–6.
  • Söderlund M, von Essen R, Haapasaari J, Kiistala U, Kiviluoto O, Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997; 349: 1063–5.
  • Cassinotti P, Burtonboy G, Fopp M, Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 1997; 53: 229–32.
  • Lundqvist A, Tolfvenstam T, Brytting M, Stolt CM, Hedman K, Broliden K. Prevalence of parvovirus B19 DNA in bone marrow of patients with hematologic disorders. Scand J Infect Dis 1999, In press.
  • Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese RM, Young NS. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 1989; 84: 1114–23.
  • Cassinotti P, Weitz M, Siegl G. Human parvovirus B19 infections: routine diagnosis by a new nested polymerase chain reaction assay. J Med Virol 1993; 40: 228–34.
  • Foto F, Saag KG, Scharosch LL, Howard EJ, Naides SJ. Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence. J Infect Dis 1993; 167: 744–8.
  • Walsh KJ, Armstrong RD, Turner AM. Brachial plexus neuropathy associated with human parvovirus infection. Br Med J 1988; 296: 896.
  • Faden H, Gary GW, Korman M. Numbness and tingling of fingers associated with parvovirus B19 infection. J Infect Dis 1990; 161: 354–5.
  • Denning DW, Amos A, Rudge P, Cohen BJ. Neuralgic amyotrophy due to parvovirus infection. J Neurol Neurosurg Psychiatr 1987; 50: 641–2.
  • Finkel T, Török T, Ferguson P, Durigon EL, Zaki SR, Leung DYM, et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or etiological agent? Lancet 1994; 343: 1255–8.
  • Kerr JR, Curran MD, Moore JE, Coyle PV, Ferguson WP. Persistent parvovirus B19 infection. Lancet 1995; 345: 1118.
  • Moutsopoulos H, Papadopoulos G, Youinou P. Gougerot-Sjogren syndrome: the viruses in the box of the accused. Ann Med Interne 1994; 145: 25–31.
  • Young NS. Parvovirus infection and its treatment. Clin Exp Immunol 1996; 104 Suppl 1: 26–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.